Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.
Tutrone R, Lowentritt B, Neuman B, Donovan MJ, Hallmark E, Cole TJ, Yao Y, Biesecker C, Kumar S, Verma V, Sant GR, Alter J, Skog J. Tutrone R, et al. Among authors: alter j. Prostate Cancer Prostatic Dis. 2023 Sep;26(3):596-601. doi: 10.1038/s41391-023-00675-1. Epub 2023 May 16. Prostate Cancer Prostatic Dis. 2023. PMID: 37193776 Free PMC article. Clinical Trial.
Family nurse practitioners in Eastern Kentucky.
Kirk RF, Alter JD, Browne HE, Davis J. Kirk RF, et al. Among authors: alter jd. Med Care. 1971 Mar-Apr;9(2):160-8. doi: 10.1097/00005650-197103000-00008. Med Care. 1971. PMID: 4396596 No abstract available.
Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy.
Kretschmer A, Kajau H, Margolis E, Tutrone R, Grimm T, Trottmann M, Stief C, Stoll G, Fischer CA, Flinspach C, Albrecht A, Meyer L, Priewasser T, Enderle D, Müller R, Torkler P, Alter J, Skog J, Noerholm M. Kretschmer A, et al. Among authors: alter j. Sci Rep. 2022 Mar 21;12(1):4777. doi: 10.1038/s41598-022-08608-z. Sci Rep. 2022. PMID: 35314720 Free PMC article.
Correction to: ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.
Tutrone R, Lowentritt B, Neuman B, Donovan MJ, Hallmark E, Cole TJ, Yao Y, Biesecker C, Kumar S, Verma V, Sant GR, Alter J, Skog J. Tutrone R, et al. Among authors: alter j. Prostate Cancer Prostatic Dis. 2024 Mar;27(1):161. doi: 10.1038/s41391-023-00681-3. Prostate Cancer Prostatic Dis. 2024. PMID: 37337052 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 38580266
[No title available]
[No authors listed] [No authors listed] PMID: 38579883
Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients.
Den RB, Santiago-Jimenez M, Alter J, Schliekelman M, Wagner JR, Renzulli Ii JF, Lee DI, Brito CG, Monahan K, Gburek B, Kella N, Vallabhan G, Abdollah F, Trabulsi EJ, Lallas CD, Gomella LG, Woodlief TL, Haddad Z, Lam LL, Deheshi S, Wang Q, Choeurng V, du Plessis M, Jordan J, Parks B, Shin H, Buerki C, Yousefi K, Davicioni E, Patel VR, Shah NL. Den RB, et al. Among authors: alter j. Prostate Cancer Prostatic Dis. 2016 Dec;19(4):374-379. doi: 10.1038/pcan.2016.38. Epub 2016 Aug 30. Prostate Cancer Prostatic Dis. 2016. PMID: 27574020 Free PMC article.
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.
Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL. Spratt DE, et al. Among authors: alter j. J Clin Oncol. 2018 Feb 20;36(6):581-590. doi: 10.1200/JCO.2017.74.2940. Epub 2017 Nov 29. J Clin Oncol. 2018. PMID: 29185869 Free PMC article.
100 results